A carregar...
Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery
Liposomal nanoparticles are a heterogeneous group of engineered drug carriers that have tremendous therapeutic potential in the treatment of cancer. They increase tumor drug delivery, significantly attenuate drug toxicity, and protect the drug from degradation. However, two decades after approval of...
Na minha lista:
| Publicado no: | Front Pharmacol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6422978/ https://ncbi.nlm.nih.gov/pubmed/30914953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00220 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|